Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06627517 · ClinicalTrials.gov registry record · NA
Safety and Effectiveness of the Luna System in People With Type 1 Diabetes Mellitus
A NA study of Type 1 Diabetes Mellitus and Sleep Quality, sponsored by Luna Diabetes.
- Active
- Registry status
- NA
- Development phase
- 120
- Enrollment target
- 3
- Study locations
NCT06627517 is a NA study of Type 1 Diabetes Mellitus and Sleep Quality that is active but no longer recruiting, run by Luna Diabetes. The registered enrollment target is 120 participants, below the 139-participant average among 105 other Type 1 Diabetes Mellitus trials with a reported enrollment target (14% lower). The trial reports 3 study locations across 3 states.
The verdict
NCT06627517, a NA study of Type 1 Diabetes Mellitus and Sleep Quality, is active but no longer recruiting, sponsored by Luna Diabetes.
- ACTIVE NOT RECRUITING
- Registry status
- NA
- Development phase
- 120 participants
- Enrollment target
- 3
- Study locations
Study Summary
The purpose of this research is to evaluate the effect of a wearable insulin pump on blood sugar levels during sleep. The study device works with continuous glucose monitors (CGM) to calculate and deliver rapid-acting insulin doses during sleep. The study device does not replace long-acting, correction, or mealtime insulin. The study will involve applying the study device before bed for a period of 13 weeks. The overall study length is approximately 17 weeks. The study aims to evaluate whether the study device is safe and if it lowers blood sugar levels in people who have consistently high blood sugar during sleep and at wake.
Conditions Studied
Interventions
- DEVICE Episodic overnight patch pump
Study Locations (3)
California
- Diablo Clinical Research - Walnut Creek
Colorado
- Barbara Davis Center for Diabetes - Aurora
Minnesota
- International Diabetes Center - Minneapolis
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 120 participants |
| Start Date | 2024-11-22 |
| Est. Completion | 2025-12 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT06627517
The ClinicalTrials.gov registry entry for NCT06627517 describes a study currently listed as active not recruiting, categorized as NA. The registered enrollment target is 120 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 139-participant average among 105 other Type 1 Diabetes Mellitus trials with a reported enrollment target (14% lower). The listed sponsor is Luna Diabetes, which has 1 total studies on file at ClinicalTrials.gov.
The record links to 2 conditions, with Type 1 Diabetes Mellitus appearing as the primary indexed condition, and to 1 intervention - of which Episodic overnight patch pump is the first listed.
NCT06627517 reports 3 study locations spanning 3 distinct geographic areas - top geographies include California, Colorado, Minnesota.
Frequently Asked Questions
What is clinical trial NCT06627517 about?
NCT06627517 is a clinical study titled "Safety and Effectiveness of the Luna System in People With Type 1 Diabetes Mellitus". The purpose of this research is to evaluate the effect of a wearable insulin pump on blood sugar levels during sleep. The study device works with continuous glucose monitors (CGM) to calculate and deliver rapid-acting insulin doses during sleep. The study device does not replace long-acting, correct...
What is the current status of trial NCT06627517?
This trial is currently active not recruiting. It is a NA study. The enrollment target is 120 participants. The study started on 2024-11-22. Estimated completion is 2025-12.
What conditions does trial NCT06627517 study?
This clinical trial studies the following conditions: Type 1 Diabetes Mellitus, Sleep Quality.
What interventions are being tested in trial NCT06627517?
The interventions under investigation include: Episodic overnight patch pump (DEVICE).
Who is sponsoring clinical trial NCT06627517?
This trial is sponsored by Luna Diabetes, which has 1 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06627517 being conducted?
This trial has 3 study locations across California, Colorado, Minnesota. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Type 1 Diabetes Mellitus
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Accuracy and Precision of the Continuous Glucose Monitoring System 'CareSens Air 3' in Adult Patients With T1DM
RECRUITING · NA
-
Implementing the Spotlight AQ Platform in Adolescent/ Young Adult (16-25 Years Old) Type 1 Diabetics (T1D)
RECRUITING · NA
-
A Hybrid Effectiveness-implementation Trial to Reduce Diabetes Distress in Teenagers
RECRUITING · NA
-
PACTAID App in Adults With Type 1 Diabetes to Help Manage Exercise
RECRUITING · NA
-
GATEWAY: Safety Evaluation of the MiniMed™ NMX8-AID System in Children and Adults Living With Diabetes
RECRUITING · NA
-
Prevention of de Novo Allosensitization in Islet Transplant Recipients Following Complete Graft Loss
RECRUITING · NA
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.